Report on History of FDA and NMPA and Traditional and Future Methods of Treating Cancer

Abstract

The rate of having cancer has been growing increasingly fast nowadays. Among all the types discovered non-small cell lung cancer is the most commonly diagnosed globally; there are traditional and new methods of treating it. FDA is the most prominent institution of applying drugs to the market. There are mainly four phases before a drug is formally used to the market. In this review the Food and Drug Administration and China Food and Drug Administration work together with the four phases. Then it describes the traditional and new method of treating non-small cell lung cancer. Finally, future suggestions are mentioned in the review.